Bringing Clinical Trials to Life

Dermatology

Together, Cu-Tech and Synteract create the leading dermatology CRO, with global capabilities and unparalleled access to sites and patients. Our focus on novel and required dermatology drugs provides dedicated research services unmatched in the market.
More...

Neuro Degenerative

Neuro degenerative disorders are some of the most confounding and complex to affect people. Our specialized experience in these trials aids you in developing treatments that improve functioning and help the lives of both patients and caregivers…
More...

Oncology

Like our clients, we are committed to the quest to cure cancer. But cancer is not just a single disease. It takes deep trial knowledge to know how to address its many forms. Learn how Synteract has stayed ahead of the trends leading towards new treatments…
More...

Pediatrics

Pediatric trials run the gamut of indications in drug development, but they all have primary things in common – working with children and their families requires specialized expertise and deep knowledge of regulatory requirements….
More...

Rare & Orphan Diseases

Rare and orphan diseases have unique characteristics, not the least of which is finding the right population for your trials. We know the investigators and study sites that can help to address your recruitment goals, among other challenges…
More...

2/12/2019 - 2/13/2019 : Outsourcing in Clinical Trials West Coast Booth # 21 More...

11/15/2018: Synteract has acquired KinderPharm, a specialty pediatric CRO, focused on advancing pediatric drug development across all phases of clinical research. More...

11/20/2018: 5 Reasons to Work with Synteract For Your Pediatric Clinical Trial - Whether you are looking for small scale support, assistance with a specific service, or complete study design and management, Synteract draws on extensive, end-to-end experience in helping clients efficiently navigate the complexities of pediatric trials and regulatory environments.

Synteract Blog 

1/23/2019: Whether your #oncology trial is in the early planning stages or at the point where you are selecting a CRO partner, our teams successfully manages all phases of oncology studies and can work with you to advance your next trial: http://ow.ly/ij4g50kh3G8

Synteract on LinkedIn

1/22/2019: Recruitment is one of the biggest challenges facing rare and orphan studies. We have cultivated key relationships w… https://t.co/jCwsVKAo50

Synteract Twitter Feed
x

Submit RFI / RFP

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

Required

x

Contact Synteract

Tell us how to stay in touch with you:

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

Required

x

Download Resource

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

*Required